1. Home
  2. HSHP vs OABI Comparison

HSHP vs OABI Comparison

Compare HSHP & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSHP
  • OABI
  • Stock Information
  • Founded
  • HSHP 2021
  • OABI 2012
  • Country
  • HSHP Bermuda
  • OABI United States
  • Employees
  • HSHP N/A
  • OABI N/A
  • Industry
  • HSHP
  • OABI Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSHP
  • OABI Health Care
  • Exchange
  • HSHP Nasdaq
  • OABI Nasdaq
  • Market Cap
  • HSHP 268.6M
  • OABI 240.5M
  • IPO Year
  • HSHP 2023
  • OABI N/A
  • Fundamental
  • Price
  • HSHP $7.40
  • OABI $2.01
  • Analyst Decision
  • HSHP
  • OABI Strong Buy
  • Analyst Count
  • HSHP 0
  • OABI 3
  • Target Price
  • HSHP N/A
  • OABI $6.67
  • AVG Volume (30 Days)
  • HSHP 130.1K
  • OABI 480.3K
  • Earning Date
  • HSHP 08-08-2025
  • OABI 08-06-2025
  • Dividend Yield
  • HSHP 5.68%
  • OABI N/A
  • EPS Growth
  • HSHP N/A
  • OABI N/A
  • EPS
  • HSHP 0.14
  • OABI N/A
  • Revenue
  • HSHP $120,680,000.00
  • OABI $23,027,000.00
  • Revenue This Year
  • HSHP $8.95
  • OABI N/A
  • Revenue Next Year
  • HSHP $24.00
  • OABI $45.02
  • P/E Ratio
  • HSHP $54.06
  • OABI N/A
  • Revenue Growth
  • HSHP 44.77
  • OABI 6.05
  • 52 Week Low
  • HSHP $4.29
  • OABI $1.22
  • 52 Week High
  • HSHP $8.74
  • OABI $4.87
  • Technical
  • Relative Strength Index (RSI)
  • HSHP 63.75
  • OABI 54.14
  • Support Level
  • HSHP $7.13
  • OABI $1.69
  • Resistance Level
  • HSHP $7.62
  • OABI $2.09
  • Average True Range (ATR)
  • HSHP 0.17
  • OABI 0.11
  • MACD
  • HSHP 0.02
  • OABI -0.01
  • Stochastic Oscillator
  • HSHP 77.01
  • OABI 80.25

About HSHP Himalaya Shipping Ltd.

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: